Incyte said on Monday its experimental combo therapy helped patients with a type of blood cancer live longer without their ...

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, ...

Incyte said on Monday its experimental combo therapy helped patients live longer without their disease worsening in a late-stage study of a type of blood cancer, sending its shares up about 3% in ...

Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical ...

The FDA-approved drug combination specifically targets low-grade serous ovarian cancer, which primarily affects younger women ...

Randomness inside cells can decide whether a cancer returns after chemotherapy or whether an infection survives antibiotics.

A recently published study found that targeted radiation delivered before surgery can eradicate certain early-stage ...

Researchers at the UNC School of Medicine and the UNC Eshelman School of Pharmacy have made a breakthrough that could ...

Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...

Join the audience for a live webinar at 4 p.m. GMT on 17 February 2026 Upright patient positioning opens new pathways for radiation therapy in cancer care ...

Patients’ fatigue levels before starting systemic cancer treatment predict their risk for severe or fatal side effects.

Gastric cancer cells can activate KRAS-driven signals, enabling autonomous tumor growth by producing their own WNT proteins. New research reveals how gastric cancer cells exploit WNT signaling for ...